Precision Oncology Resources: Webinars
Sponsored by Olink
Using NGS-Based Proteomics to Differentiate BTK Inhibitor Response in Leukemia
Treatment of chronic lymphocytic leukemia (CLL) has been revolutionized by targeted therapies, especially BTK inhibitors (BTKi), which block signaling of the B cell receptor, depriving leukemia cells of survival signals. BTKi have significantly improved the survival of CLL patients and are now a preferred standard therapy for CLL.
This webinar will highlight a study that set out to compare the effect of three different BTK inhibitors: ibrutinib, acalabrutinib, and zanubrutinib. Patient samples were obtained before and at various timepoints after treatment to identify biomarkers that could be informative of the treatment’s effect and potential side effects.
In the study, a new method from Olink, called Olink Reveal, enabled the identification of numerous proteins. The method quantifies more than 1,000 proteins, representing a full range of biological pathways across the proteome, and is enriched with hundreds of proteins involved in inflammation processes. This approach enabled the identification of numerous proteins, including those differing between the studied compounds, and shows promise for other studies seeking to compare the effects of different cancer treatments.
This presentation will share the first data to characterize the effects of the different BTKi on plasma biomarker levels and will be followed by an introduction to Olink Reveal.
Presenters:
C. I. Edvard Smith, Professor, Department of Laboratory Medicine at the Karolinska Institute
Kerhan Woo, Product Manager, Olink Proteomics
Sponsored by

Sponsored by Agena Bioscience
Expert Panel: Guideline-Driven Pharmacogenomic Testing and the Trajectory of Utilization
In this webinar, attendees will hear from a panel of experts in the pharmacogenomics (PGx) space. These thought leaders will discuss consensus recommendations for standardization of alleles for pharmacogenomic genotyping assays. Attendees will gain insights into these evidence-based guidelines and the implementation of standardized PGx testing within the laboratory. This panel discussion will provide insights into the trajectory of PGx utilization, including challenges, future considerations, and the potential benefits to healthcare.
Sponsored by

Sponsored by Illumina
Scaling the Genomics Lab for the Data Deluge: Streamlined and Efficient Data Analysis Workflows as a Strategic Pillar for Growth
The exponential growth of genomic data has created both opportunities and challenges for laboratories striving to scale operations across service lines. To address this data deluge, leveraging bioinformatics as a core strategy has become essential.
This webinar will explore how a leading genomics lab, the Advanced Precision Medicine Laboratory (APML) at the Jackson Laboratory, harnesses a streamlined bioinformatics workflow to enhance data integration and support scalability while maintaining accuracy and efficiency. APML has implemented Illumina Connected Software covering all their data needs from LIMS through analysis and variant interpretation. Melissa Kelly, clinical laboratory director of the Advanced Precision Medicine Laboratory, will explore how an integrated data ecosystem from sample management through interpretation helps her team get the result they can trust faster.
Kevin Moore, vice president of software product management at Illumina, will wrap up the presentation with a quick overview of the upcoming software advancements and how it will enable seamless end-to-end multiomics workflows.
Attendees will learn to:
- Build effective lab infrastructure with practical approaches.
- Align bioinformatics solutions with operational needs.
- Position labs for sustainable growth in an era of increasing data complexity.
- Harness the latest advancements in Illumina software that enable seamless integrated multiomics workflows.
Sponsored by

Multiomics in Precision Medicine 2025
Registration is open for Multiomics in Precision Medicine 2025!
This event, developed in partnership with the University of Pennsylvania Institute for Biomedical Informatics, will explore how multiomics methods are advancing precision medicine in a range of human disease areas.
Keynotes
- Muzz Haniffa: Biological Network Co-Coordinator, Human Cell Atlas
- Marinka Zitnik: Assistant Professor, Dept of Biomedical Informatics, Harvard
- Maya Ghoussaini: Executive Director, Computational Genomics and Application Development, Regeneron Genetics Center
On Demand: Multiomics in Precision Medicine 2024
This event, part of the Precision Medicine Leaders’ Summit conference series and developed in partnership with the University of Pennsylvania Institute for Biomedical Informatics, took place June 25 - 26, 2024
The conference explored how multiomics methods are advancing precision medicine in a range of human disease areas.
Recent advances in multiomic approaches — including genomics, transcriptomics, epigenomics, proteomics, and metabolomics — enable a more comprehensive picture of disease biology. This promises to accelerate the development of precision medicine, but also presents challenges for researchers, clinicians, and health systems struggling to integrate disparate data sources into a cohesive clinical strategy.
Multiomics in Precision Medicine 2024 highlighted best practices, trends, and strategies from experts who are successfully implementing a range of omics approaches to advance molecularly informed medicine.
Advances in Single Cell and Spatial Biology 2025
Registration is open for Advances in Single Cell and Spatial Biology 2025!
This event will focus on single-cell and spatial biology technologies that are helping to drive new insights into biological research and precision medicine.